SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Sol-Gel Technologies Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026
$64.98+0.73 (+1.14%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2014 to 2025
Operating margin
-38.9%+305.8 pts over 5 years
Net margin
-31.6%+302.3 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +68.0% | +70.9% | +17.2% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 96.9% | -56.7% | -23.7% | |
| Return on assets | – | -48.6% | -18.6% | |
| Current ratio | 0.20 | 8.95 | 4.37 | |
| Capex to revenue | – | 5.1% | 0.2% | |
| Diluted shares | 1M | 2M | 3M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Sol-Gel Technologies generated $49.12M from operations and spent $497.00K on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$49.12M
Used
$497.00K
Capital expenditure$497.00K100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-31.6%
×Asset turnover0.59×
×Equity multiplier1.27×
=Return on equity, FY2025-23.7%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -31.6% | 0.59× | 1.27× | -23.7% |
| FY2024 | -91.7% | 0.28× | 1.20× | -31.4% |
| FY2023 | -1752.8% | 0.03× | 1.14× | -67.4% |
| FY2022 | -384.3% | 0.07× | 1.18× | -30.5% |
| FY2021 | 10.3% | 0.49× | 1.21× | 6.1% |
| FY2020 | -333.9% | 0.15× | 1.17× | -56.7% |
| FY2019 | -107.4% | 0.35× | 1.13× | -42.3% |
| FY2018 | -24963.6% | 0.00× | 7.58× | -574.5% |
| FY2017 | -18142.5% | 0.01× | -0.31× | 75.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$6.13M
- Cash generatingOperating cash flow above zero$322.00K
- Return on assets improvedROA up on the prior year-23.4% → -17.1%
- Earnings backed by cashOperating cash flow above net income$322.00K vs -$6.13M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose5.92 → 4.37
- No dilutionShare count did not rise3M → 3M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.25 → 0.54